BMA says government not tackling NHS problems
Guideline dilemma with new costly cholesterol therapies
NICE guidance to prevent antibacterial overuse
No investment return biggest barrier to low-cost drugs
Older insulins make glycaemic control affordable
Termination of PFI contracts may achieve NHS savings
Universal health coverage complex but achievable
Colonoscopy screening based on age alone inefficient
Conditional approval has no impact on HTA decisions
Cost-effectiveness modeling in MS: credibility questioned
Costs of generic topical corticosteroids vary
Diet and activity programs cost effective for preventing T2DM
Drug utilisation high in preterms but specific labelling scarce
Free HPV vax: more coverage, less socio-economic inequality
Healthcare price transparency not a reality
Hemangiol cost effective for proliferating infantile haemangioma
High spend on school-based care for childhood ASD in the US
Household food insecurity linked to healthcare costs
Ketoanalog supplementation cost effective in CKD
Little money incentivises HIV screening in Tanzania
Lower costs with breast cancer screening programme in Norway
Mirtazapine cost effective for MDD in Singapore
More behavioural health services needed at US health centres
Olodaterol/tiotropium improves QOL in patients with COPD
PCMHs increase healthcare use and costs in early breast cancer
Reducing frequency of pregabalin saves costs
Statin use high in very elderly in US
Surveillance of low-risk papillary thyroid cancer costly
Uninsured rates dropping in USA
US public still divided on Affordable Care Act
No QOL impact of clozapine in China
Diabetes prescribing increasing in England
Generic drug ban cancels trade talks
Highest drug spend increase in the US
National AF screening likely to be cost effective for Ireland
US healthcare benefit cost increases will hold steady